GLP-1 Receptor Agonist Effects on Lipid and Liver Profiles in Patients with Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis

Código QR

GLP-1 Receptor Agonist Effects on Lipid and Liver Profiles in Patients with Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis

Aims. This meta-analysis of randomized placebo-controlled clinical trials assessed the effect of glucose-like peptide-1-receptor agonists (GLP-1RA) on the lipid profile and liver enzymes in patients with nonalcoholic fatty liver disease (NAFLD). Materials and Methods. Randomized placebo-controlled t...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Shahla Rezaei, Reza Tabrizi, Peyman Nowrouzi-Sohrabi, Mohammad Jalali, Stephen L. Atkin, Khalid Al-Rasadi, Tannaz Jamialahmadi, Amirhossein Sahebkar
Formato:	article
Lenguaje:	EN
Publicado:	Hindawi Limited 2021
Materias:	Diseases of the digestive system. Gastroenterology RC799-869
Acceso en línea:	https://doaj.org/article/575902276a12457aaf5580741dcd481a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Association between liver fibrosis progression and endothelin-1/nitric oxide in patients with nonalcoholic fatty liver disease
por: LI Pinhua
Publicado: (2021)

Surgical treatment of nonalcoholic fatty liver disease in severely obese patients
por: Vander Naalt SJ, et al.
Publicado: (2014)

Tyrosine levels are associated with insulin resistance in patients with nonalcoholic fatty liver disease
por: Kawanaka M, et al.
Publicado: (2015)

White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in MiceSummary
por: Sadatsugu Sakane, et al.
Publicado: (2021)

A lipid-rich gestational diet predisposes offspring to nonalcoholic fatty liver disease: a potential sequence of events
por: Hughes AN, et al.
Publicado: (2014)

Hepatocyte-specific TM6SF2 knockout aggravates hepatic steatosis in mice with nonalcoholic fatty liver disease
por: ZHANG Jie
Publicado: (2021)

A serum metabolomics study on the intervention of nonalcoholic fatty liver disease by equicaloric low-carbohydrate high-protein diet combined with aerobic exercise
por: LI Meiying
Publicado: (2021)

Weekly cisplatin may reverse liver dysfunction and jaundice caused by diffuse liver metastases of solid tumors
por: M Gabrovska, et al.
Publicado: (2009)

Epidemiology of drug-induced liver injury
por: LI Xiaoyun
Publicado: (2021)

Autonomic dysfunction in chronic liver disease
por: Frith J, et al.
Publicado: (2011)

Clinical manifestations and typing of drug-induced liver injury
por: YANG Wanna
Publicado: (2021)

Drug-induced liver injury: Advances and confusions in treatment
por: CHEN Shuai
Publicado: (2021)

Pathological features and pathological diagnosis of drug-induced liver injury
por: YANG Yongfeng
Publicado: (2021)

Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients
por: Locke JE, et al.
Publicado: (2011)

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease
por: Bradford V, et al.
Publicado: (2013)

Treatment of nonalcoholic steatohepatitis with vitamins E and C: a pilot study
por: Kawanaka M, et al.
Publicado: (2013)

Autophagy: a new target for nonalcoholic fatty liver disease therapy
por: Mao YQ, et al.
Publicado: (2016)

Pathogenesis of drug-induced liver injury: Current understanding and future needs
por: YU Yuecheng
Publicado: (2021)

Endoscopic duodenal mucosal resurfacing for nonalcoholic steatohepatitis (NASH): a pilot study
por: Alia Hadefi, et al.
Publicado: (2021)

Clinical features of drug-induced liver failure and related diagnosis and treatment strategies
por: LAI Rongtao
Publicado: (2021)

Prevalence rate of non-obese fatty liver disease and related influencing factors
por: DENG Jiang
Publicado: (2021)

Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine
por: Lau T, et al.
Publicado: (2013)

Challenges of continuation of live liver donor programme during COVID-19 pandemic in Pakistan: outcomes and lessons learned
por: Azhar Hussain, et al.
Publicado: (2021)

An excerpt of Budd-Chiari syndrome: Consensus guidance of the Asian Pacific Association for the Study of the Liver (APASL)
por: WANG Xueying
Publicado: (2021)

Serum anti-modified citrullinated vimentin antibody concentration is associated with liver fibrosis in patients with chronic hepatitis
por: Suad Abdeen, et al.
Publicado: (2011)

Construction of a new patient-derived xenograft model of human liver cancer in mice with normal immunity
por: TANG Huixin
Publicado: (2021)

Direct comparison of the FibroScan XL and M probes for assessment of liver fibrosis in obese and nonobese patients
por: Durango E, et al.
Publicado: (2013)

Associations Between Alcohol Use and Liver‐Related Outcomes in a Large National Cohort of Patients With Cirrhosis
por: Meredith M. Pearson, et al.
Publicado: (2021)

A preliminary study on percutaneous transhepatic drainage combined with sequential percutaneous nephroscopy in treatment of refractory liver abscess
por: DUAN Changhu
Publicado: (2021)

Prevalence of and risk factors for non-alcoholic fatty liver disease (NAFLD) and fibrosis among young adults in Egypt
por: Osama Hamdy, et al.
Publicado: (2021)

An excerpt of diagnosis, evaluation, and management of ascites and hepatorenal syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
por: HU Jiaxuan
Publicado: (2021)

Therapeutic effect of Taohong Siwu decoction on a mouse model of carbon tetrachloride-induced liver fibrosis and its mechanism
por: LIU Xuling
Publicado: (2021)

An excerpt of EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update
por: ZHANG Yue
Publicado: (2021)

Western Diet Changes Gut Microbiota and Ameliorates Liver Injury in a Mouse Model with Human‐Like Bile Acid Composition
por: Junichi Iwamoto, et al.
Publicado: (2021)

The pathophysiology of thrombocytopenia in chronic liver disease
por: Mitchell O, et al.
Publicado: (2016)

A newborn liver mass that never existed: a somber reminder of embryonic ties between umbilical vein and portal venous system
por: Haafiz A, et al.
Publicado: (2011)

Analysis Of Risk Factors For Nonalcoholic Fatty-Liver Disease In Hepatitis B Virus Infection: A Case–Control Study
por: Azarkar G, et al.
Publicado: (2019)

Value of albumin-bilirubin grade in predicting liver function changes and prognosis of hepatocellular carcinoma patients undergoing transarterial chemoembolization: A Meta-analysis
por: YU Weiming
Publicado: (2021)

Decline in HAV-associated fulminant hepatic failure and liver transplant in children in Argentina after the introduction of a universal hepatitis A vaccination program
por: Cervio G, et al.
Publicado: (2011)

Efficacy of Glucagon-Like Peptide-1 Analogs in Nonalcoholic Fatty Liver Disease: A Systematic Review
por: Teshome G, et al.
Publicado: (2020)